Cancer Leukemia-Myelogenous-Chronic
| Title: | Clinical Evaluation of the Xpert BCR-ABL Ultra Assay on the GeneXpert Instrument Systems |
| Description: | The objective of this study is to establish the performance of an assay that detects mRNA transcript levels in patients diagnosed with CML. The study is conducted at locations within the United States. Testing is performed on peripheral blood specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions. |
| Drug/Procedure: | Xpert BCR-ABL Ultra |
| NCT Number: | 03421626 |
| Notes: | |
| Start Date: | 10/23/17 |
| Status: | Recruiting |
| Principal Name: | Alan Langerak, MD |
| Contact Name: | Olga Bittner, CCRC |
| Phone: | (208)367-7954 |
| Title: | Specimen Collection for Analytical and/or Clinical Validation Studies of the Xpert BCR-ABL Ultra Assay on the GeneXpert Instrument Systems |
| Description: | The objective of this study is to establish the performance of an assay that detects mRNA transcript levels in patients diagnosed with CML. The study is conducted at locations within the United States. Testing is performed on peripheral blood specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions. |
| Drug/Procedure: | Xpert BCR-ABL Ultra |
| NCT/HDE #: | N/A |
| Notes: | |
| Start Date: | 7/21/17 |
| Status: | Recruiting |
| Principal Name: | Alan Langerak, MD |
| Contact Name: | Olga Bittner, CCRC |
| Phone: | (208)367-7954 |